STRS Ohio’s Cymabay Therapeutics CBAY Stock Holding History

STRS Ohio’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,400	Closed	-$222K	–	2052
2023 Q4	$222K	Hold	9,400	–	–	﹤0.01%	1538
2023 Q3	$140K	Sell	9,400 -2,900	-24%	-$38.4K	﹤0.01%	1654
2023 Q2	$134K	Buy	+12,300	New	+$115K	﹤0.01%	1677
2021 Q2	–	Sell	-8,100	Closed	-$36K	–	2472
2021 Q1	$36K	Sell	8,100 -42,300	-84%	-$228K	﹤0.01%	2066
2020 Q4	$289K	Buy	50,400 +44,400	+740%	+$336K	﹤0.01%	1666
2020 Q3	$43K	Buy	+6,000	New	+$32.1K	﹤0.01%	1997
2018 Q3	–	Sell	-17,200	Closed	-$214K	–	2196
2018 Q2	$230K	Buy	+17,200	New	+$215K	﹤0.01%	1709

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

STRS Ohio's CBAY Position: Q1 2024 in Review

STRS Ohio sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 9,400 shares — an estimated $222K sold.

STRS Ohio first reported a position in CBAY in Q2 2018 and held it in 7 quarters. The position peaked at $289K in Q4 2020. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

STRS Ohio reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
STRS Ohio sold 9,400 Cymabay Therapeutics shares in Q1 2024, an estimated $222K.
STRS Ohio first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 7 quarters.
STRS Ohio's Cymabay Therapeutics position peaked at $289K in Q4 2020.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.